KAI-1678 is an inhibitor of epsilon protein kinase C in the treatment of neuropathic pain in patients with PHN.
CAT No: 10-101-144
KAI-1678 is a synthetic small molecule carbohydrate compound designed to interact selectively with specific protein targets involved in cellular signaling pathways. As a research-grade tool, KAI-1678 demonstrates unique structural features that enable it to modulate key biological processes, making it highly valuable in the investigation of molecular mechanisms underlying various physiological and pathological states. Its stability and solubility characteristics support a wide range of experimental conditions, facilitating detailed studies in both in vitro and ex vivo systems. Researchers appreciate KAI-1678 for its ability to provide reproducible results, supporting the generation of robust data in complex biological assays. The compound's versatility and specificity have positioned it as a preferred choice in advanced scientific research seeking to unravel intricate biochemical interactions.
Pain Pathway Investigation: KAI-1678 has garnered significant attention in the study of pain signaling pathways, particularly those involving protein kinase C epsilon (PKCε). By serving as a potent and selective modulator of PKCε, the compound allows researchers to dissect the role of this kinase in nociceptive transmission and sensitization. Through targeted application in neuronal cell models, scientists can elucidate the downstream effects of PKCε activation or inhibition, contributing to a deeper understanding of how pain signals are generated and propagated at the molecular level. This mechanistic insight is crucial for identifying potential intervention points in chronic pain conditions.
Neuroscience Research: In the field of neuroscience, KAI-1678 is utilized to explore the modulation of synaptic plasticity and neuronal excitability. Its interaction with specific signaling cascades enables the study of how alterations in kinase activity influence neurophysiological processes such as long-term potentiation and depression. Experimental models employing this compound have provided valuable data regarding the molecular underpinnings of learning, memory, and neuroadaptive responses. By delineating the contributions of PKCε and related pathways, investigators can better characterize the molecular architecture of neural circuits and their dynamic regulation.
Inflammatory Mechanism Studies: The use of KAI-1678 extends to research on inflammation, where it aids in dissecting the cellular responses to pro-inflammatory stimuli. Through its ability to modulate kinase-mediated signaling, the compound facilitates the investigation of cytokine release, immune cell activation, and the amplification of inflammatory cascades. Studies employing KAI-1678 have contributed to the identification of critical checkpoints within the inflammatory response, offering insights into the molecular dialogue between immune cells and their microenvironment. Such research is instrumental in mapping the regulatory networks that govern inflammation and tissue homeostasis.
Signal Transduction Analysis: KAI-1678 serves as a valuable probe in the broader context of signal transduction research. Its selective action on PKCε and related kinases allows for precise manipulation of signaling pathways involved in cellular proliferation, differentiation, and survival. By incorporating the compound into biochemical assays or cell-based systems, researchers can monitor the activation status of downstream effectors, unravel cross-talk between signaling modules, and assess the impact of targeted interventions. This application is particularly relevant for studies aiming to decode the complexity of intracellular communication networks.
Drug Discovery and Development: In pharmaceutical research, KAI-1678 is employed as a reference compound or lead structure in the screening and optimization of new molecular entities targeting kinase-mediated pathways. Its well-characterized mechanism of action and selectivity profile provide a benchmark for evaluating the efficacy and specificity of novel candidates. By integrating KAI-1678 into high-throughput screening platforms or structure-activity relationship studies, medicinal chemists can accelerate the identification and refinement of promising modulators, thereby advancing the early stages of drug discovery focused on pain, inflammation, and neurobiological disorders.
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More